Advocacy intelligence hub — real-time data for patient organizations
M.D. Anderson Cancer Center — NA
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — PHASE2, PHASE3
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore — NA
Instituto do Cancer do Estado de São Paulo — PHASE2
Algemeen Ziekenhuis Maria Middelares — NA
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
M.D. Anderson Cancer Center
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Blenoxane
Bristol-Myers Squibb Pharmaceutical Research Institute
CINACALCET
(CINACALCET)standardAurobindo Pharma Limited
12.1 Mechanism of Action The calcium-sensing receptor on the surface of the chief cell of the parathyroid gland is the principal regulator of PTH synt...
Nancy D. Perrier, MD, M.D
M.D. Anderson Cancer Center
📍 HOUSTON, TX
Nancy Perrier, M.D
M.D. Anderson Cancer Center
📍 HOUSTON, TX
Sandip P Patel
SWOG Cancer Research Network
📍 Birmingham, Alabama
Camila MV Moniz, Doctor
Oncologist
📍 SAN ANTONIO, TX
Smita Jha, M.D., M.D
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
📍 BETHESDA, MD
Carmen C Solorzano, MD, FACS
Vanderbilt University Medical Center
📍 OAKLAND, CA